1;Foreword I;23 2;Foreword II;27 3;Preface;29 4;Author index;37 5;Abbreviations;41 6;Part I: INTERFACE OF DERMATOLOGY AND PSYCHIATRY;47 6.1;1 Perspectives on management of pediatric dermatologie disorders;49 6.1.1;1.1 Introduction;49 6.1.2;1.2 Skin infections and infestations;49 6.1.2.1;1.2.1 Bacterial infections;49 6.1.2.2;1.2.2 Viral infections;61 6.1.3;1.3 HIV/AIDS;65 6.1.3.1;1.3.1 Non-infectious skin lesions;65 6.1.3.2;1.3.2 Bacterial infections in HIV;65 6.1.3.3;1.3.3 Viral infections in HIV;66 6.1.3.4;1.3.4 Fungal infections in HIV;66 6.1.3.5;1.3.5 Fungal infections;67 6.1.3.6;1.3.6 Topical antifungals;71 6.1.3.7;1.3.7 Infestations;72 6.1.4;1.4 Dermatitis;75 6.1.4.1;1.4.1 Irritant dermatitis;75 6.1.4.2;1.4.2 Dry-skin dermatitis;75 6.1.4.3;1.4.3 Seborrheic dermatitis;75 6.1.4.4;1.4.4 Allergic dermatitides;76 6.1.4.5;1.4.5 Idiopathic dermatitides;79 6.1.5;1.5 Hypersensitivity;79 6.1.5.1;1.5.1 Urticaria;79 6.1.5.2;1.5.2 Drug eruptions;81 6.1.6;1.6 Miscellaneous skin conditions;83 6.1.6.1;1.6.1 Acne vulgaris;83 6.1.6.2;1.6.2 Nevi;87 6.1.6.3;1.6.3 Papulosquamous disorders;90 6.1.6.4;1.6.4 Lichens;92 6.1.6.5;1.6.5 Psoriasis;95 6.1.7;1.7 Dermatologic manifestations of systematic disorders;98 6.1.7.1;1.7.1 Pruritus without rash;98 6.1.7.2;1.7.2 Inflammatory bowel disease (IBD);99 6.1.7.3;1.7.3 Erythema nodosum;99 6.1.7.4;1.7.4 Pyoderma gangrenosum;99 6.1.7.5;1.7.5 Less common skin manifestations;99 6.1.7.6;1.7.6 Management;99 6.1.8;1.8 Collagen vascular disease;100 6.1.8.1;1.8.1 Lupus erythematosus (SLE);100 6.1.8.2;1.8.2 Dermatomyositis;100 6.1.8.3;1.8.3 Juvenile idiopathic arthritis;100 6.1.8.4;1.8.4 Management;100 6.1.9;1.9 Endocrinologic disorders;101 6.1.9.1;1.9.1 Thyroid disorders;101 6.1.9.2;1.9.2 Diabetes mellitus;101 6.1.9.3;1.9.3 Adrenal disorders;101 6.1.9.4;1.9.4 Management;102 6.1.10;1.10 Hair and nails;102 6.1.10.1;1.10.1 Alopecia areata;102 6.1.10.2;1.10.2 Telogen effluvium;104 6.1.10.3;1.10.3 Androgenic alopecia;104 6.1.10.4;1.10.4 Trichotillomania;105 6.1.10.5;1.10.5 Traction alopecia;105 6.1.10.6;1.10.6 Hirsutism and hypertrichosis;105 6.1.10.7;1.10.7 Hair changes with systemic disease;106 6.1.10.8;1.10.8 Infection;106 6.1.10.9;1.10.9 Bacterial;108 6.1.10.10;1.10.10 Fungal;109 6.1.10.11;1.10.11 Onychodystrophy;110 6.1.10.12;1.10.12 Nail changes with systemic and nutritional disorders;111 6.2;2 Psychoneuroimmunology and other interactions between skin and psyche;115 6.2.1;2.1 Introduction;115 6.2.1.1;2.1.1 History of psychodermatology;116 6.2.1.2;2.1.2 Classification of psychodermatologic disorders;118 6.2.1.3;2.1.3 Psychological perspective of skin;118 6.2.1.4;2.1.4 Skin, mind, and the embryological embrace;120 6.2.2;2.2 Psychoneuroimmunology;121 6.2.2.1;2.2.1 Neuroendocrine response to stress;121 6.2.2.2;2.2.2 Immune response and central nervous system;122 6.2.2.3;2.2.3 Immune response and peripheral nervous system;123 6.2.2.4;2.2.4 Immune response and skin disease;123 6.2.2.5;2.2.5 Immune response and psychiatric disease;125 6.2.3;2.3 Conclusion;126 6.3;3 A clinician's approach to psychocutaneous diseases in adolescents: Untying the Gordian knot;129 6.3.1;3.1 Introduction;129 6.3.1.1;3.1.1 History taking skills in adolescent patients;129 6.3.2;3.2 Interviewing the adolescent patient;131 6.3.2.1;3.2.1 Confidentiality;133 6.3.2.2;3.2.2 Parental confidentiality;133 6.3.2.3;3.2.3 Health questionnaires;133 6.3.2.4;3.2.4 Interview techniques;134 6.3.2.5;3.2.5 Active listening skills;135 6.3.3;3.3 Concepts of the physical examination;136 6.3.4;3.4 Successful management of the adolescent patient;136 6.3.4.1;3.4.1 Informed consent;136 6.3.4.2;3.4.2 Shared decision makings;137 6.3.4.3;3.4.3 Improving compliance;138 6.3.5;3.5 Conclusion;138 6.4;4 Quality of life issues in children and adolescents with dermatological conditions and their wider impact on the family and society;141 6.4.1;4.1 Introduction;141 6.4.2;4.2 Pediatric quality of life and its assessment;142 6.4.3;4.3 Skin disease and quality of life;143 6.4.3.1;4.